Literature DB >> 27112334

Maximizing Lumen Gain With Directional Atherectomy.

Gregory A Stanley1, John G Winscott2.   

Abstract

PURPOSE: To describe the use of a low-pressure balloon inflation (LPBI) technique to delineate intraluminal plaque and guide directional atherectomy in order to maximize lumen gain and achieve procedure success. TECHNIQUE: The technique is illustrated in a 77-year-old man with claudication who underwent superficial femoral artery revascularization using a HawkOne directional atherectomy catheter. A standard angioplasty balloon was inflated to 1 to 2 atm during live fluoroscopy to create a 3-dimensional "lumenogram" of the target lesion. Directional atherectomy was performed only where plaque impinged on the balloon at a specific fluoroscopic orientation. The results of the LPBI technique were corroborated with multimodality diagnostic imaging, including digital subtraction angiography, intravascular ultrasound, and intra-arterial pressure measurements.
CONCLUSION: With the LPBI technique, directional atherectomy can routinely achieve <10% residual stenosis, as illustrated in this case, thereby broadly supporting a no-stent approach to lower extremity endovascular revascularization.
© The Author(s) 2016.

Entities:  

Keywords:  atherectomy; balloon angioplasty; claudication; critical limb ischemia; intravascular ultrasound; limb salvage; peripheral artery disease; residual stenosis; revascularization

Mesh:

Year:  2016        PMID: 27112334     DOI: 10.1177/1526602816644914

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  1 in total

1.  Combined HawkOne directional atherectomy and paclitaxel-coated balloon angioplasty for isolated calcified popliteal artery lesion: a no-stent approach to lower extremity endovascular revascularization.

Authors:  Romaric Loffroy; Olivier Chevallier; Nicolas Falvo; Sophie Gehin; Marco Midulla; Christophe Galland
Journal:  Quant Imaging Med Surg       Date:  2018-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.